Antigenic analysis for vaccines and diagnostics

Advances in Experimental Medicine and Biology

Volumn 984, Issue , 2012, Pages 299-328

  Hendrix, Laura R ^a   Chen, Chen ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Antigens; Coxiella burnetii; Diagnostics; Immunogenic proteins; Vaccines

Indexed keywords

B LYMPHOCYTE ANTIGEN; CHLOROQUINE; DOXYCYCLINE; IMMUNOGLOBULIN G; Q FEVER VACCINE; T LYMPHOCYTE ANTIGEN;

AGGLUTINATION TEST; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ARTICLE; BACTERIUM ISOLATE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; COXIELLA BURNETII; DISEASE SEVERITY; DNA DETERMINATION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MASS SPECTROMETRY; MICROBIAL DIVERSITY; NONHUMAN; OPEN READING FRAME; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; Q FEVER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; COXIELLA BURNETII; HUMANS; Q FEVER;

ANIMALIA; BACTERIA (MICROORGANISMS); COXIELLA BURNETII;

EID: 84863757677     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4315-1_16     Document Type: Article

References (123)

1. Ackland JR, Worswick DA, marmion BP (1994) Vaccine prophylaxis of Q fever. A follow-up study of the ef ficacy of Q-Vax (CSL) 1985-1990. Med J Aust 160:704-708
2. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE (2007) T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 75:3245-3255
3. Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Rodolakis A (2005) Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats. Vaccine 23:4392-4402
4. Arricau-Bouvery N, Hauck Y, Bejaoui A, Frangoulidis D, Bodier CC, Souriau A, Meyer H, Neubauer H, Rodolakis A, Vergnaud G (2006) Molecular characterization of Coxiella burnetii isolates by infrequent restriction site-PCR and MLVA typing. BMC Microbiol 6:38-51
5. Baca OG, Paretsky D (1983) Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev 47:127-149
6. Beare PA, Samuel JE, Howe D, Virtaneva K, Porcella SF, Heinzen RA (2006) Genetic diversity of the Q fever agent. Coxiella burnetii , assessed by microarray-based whole-genome comparisons. J Bacteriol 188:2309-2324
7. Beare PA, Chen C, Bouman T, Pablo J, Unal B, Cockrell DC, Brown WC, Barbian KD, Porcella SF, Samuel JE, Felgner PL, Heinzen RA (2008) Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin Vaccine Immunol 15:1771-1779
8. Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, Gilk SD, Williams KP, Sobral BW, Kupko JJ III, Porcella SF, Samuel JE, Heinzen RA (2009) Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella . Infect Immun 77:642-656
9. Benenson AS (1959) Q fever vaccine: ef ficacy and present status. In: Smadel JE (ed) Walter Reed Army Institute of Medical Science, Publ No 6th edn. US Government Printing Of fice, Washington, DC, p 47
10. Bengtson IA (1941) Complement fixation in "Q" fever. Proc Soc Exp Biol Med 46:665
11. Benson G (1999) Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 27:573-580
12. Bilberstein EL, Riemann HP, Franti CE, Behymer DE, Ruppanner R, Bushnell R, Crenshaw G (1977) Vaccination of dairy cattle against Q fever ( Coxiella burnetii ): results of field trials. Am J Vet Res 38:189-193
13. Bildfell RJ, Thomson GW, Haines DM, McEwen BJ, Smart N (2000) Coxiella burnetii infection is associated with placentitis in cases of bovine abortion. J Vet Diagn Invest 12:419-425
14. Brennan RE, Russell K, Zhang G, Samuel JE (2004) Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect Immun 72:6666-6675
15. Brooks DL, Ermel RW, Franti CE, Ruppanner R, Behymer DE, Williams JC (1986) Q fever vaccination of sheep: challenge of immunity in ewes. Am J Vet Res 47:1235-1238
16. Brown GL (1973) Clinical aspects of "Q" fever. Postgrad Med J 49:539-541
17. Burnet FM, Freeman M (1937) Experimental studies on the virus of "Q" fever. Med J Aust 2:299-305
18. Carrieri MP, Tissot-Dupont H, Rey D, Brousse P, Renard H, Obadia Y, Raoult D (2002) Investigation of a slaughterhouse-related outbreak of Q fever in the French Alps. Eur J Clin Microbiol Infect Dis 21:17-21
19. Chen C, Bouman TJ, Beare PA, Mertens K, Zhang GQ, Russell-Lodrique KE, Hogaboam JP, Peters B, Felgner PL, Brown WC, Heinzen RA, Hendrix LR, Samuel JE (2009) A systematic approach to evaluate humoral and cellular immune responses to Coxiella burnetii antigens. Clin Microbiol Infect 15:156-157
20. Chen C, Dow C, Wang P, Sidney J, Read A, Harmsen A, Samuel JE, Peters B (2011) Identi fication of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses. PLoS One 6:e17712
21. Coleman SA, Fischer ER, Cockrell DC, Voth DE, Howe D, Mead DJ, Samuel JE, Heinzen RA (2007) Proteome and antigen pro filing of Coxiella burnetii developmental forms. Infect Immun 75:290-298
22. Dellacasagrande J, Ghigo E, Raoult D, Capo C, Mege JL (2002) IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. J Immunol 169:6309-6315
23. Denison AM, massung RF, Thompson HA (2007a) Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii . FEMS Microbiol Lett 267:102-107
24. Denison AM, Thompson HA, massung RF (2007b) IS1111 insertion sequences of Coxiella burnetii: characterization and use for repetitive element PCR-based differentiation of Coxiella burnetii isolates. BMC Microbiol 7:91-98
25. Deringer JR, Chen C, Samuel JE, Brown WC (2011) Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identi fied by tandem mass spectrometry. Microbiology 157:526-542
26. Derrick EH (1937) "Q" fever, a new entity: clinical features, diagnosis and laboratory investigation. Med J Aust 2:281-299
27. Dilbeck PM, McElwain TF (1994) Immunohistochemical detection of Coxiella burnetii in formalin- fixed placentas. J Vet Diagn Invest 6:125-127
28. Domingues P, Palkovic P, Toman R (2002) Analysis of phospholipids from Coxiella burnetii by fast atom bombardment mass spectrometry. A rapid method for differentiation of virulent phase I and low virulent phase II cells. Acta Virol 46:121-124
29. Dupont HT, Thirion X, Raoult D (1994) Q fever serology: cut off determination for microimmuno fluorescence. Clin Diagn Lab Immunol 1:189-196
30. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 12:181-207
31. Enserink M (2010) Infectious diseases. Questions abound in Q-fever explosion in the Netherlands. Science 327:266-277
32. Fenollar F, Fournier PE, Raoult D (2004) Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infections. J Clin Microbiol 42:4919-4924
33. Fernandes I, Rousset E, Dufour P, Sidi-Boumedine K, Cupo A, Thiery R, Duquesne V (2009) Evaluation of the recombinant heat shock protein B (HspB) of Coxiella burnetii as a potential antigen for immunodiagnostic of Q fever in goats. Vet Microbiol 134:300-304
34. Field PR, Santiago A, Chan SW, Patel DB, Dickeson D, Mitchell JL, Devine PL, Murphy AM (2002) Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting Coxiella burnetii -speci fic immunoglobulin G for Q fever prevaccination screening and diagnosis. J Clin Mirobiol 40:3526-3529
35. Fishbein DB, Raoult D (1992) A cluster of Coxiella burnetii infections associated with exposure to vaccinated goats and their unpasteurized dairy products. Am J Tropic Med Hyg 47:35-40
36. Flores-Ramirez G, Toman R, Sekyova Z, Skultety L (2009) In silico prediction and identi fication of outer membrane proteins and lipoproteins from Coxiella burnetii by the mass spectrometry techniques. Clin Microbiol Infect 15:196-197
37. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D (1996) Modi fication of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocoarditis. Am J Med 100:629-633
38. Fournier P-E, Raoult D (2003) Comparison of PCR and serology assays for early diagnosis of acute Q fever. J Clin Microbiol 41:5094-5098
39. Frangoulidis D, Schropfer E, Al Dahouk S, Tomaso H, Meyer H (2006) Comparison of four commercially available assays for the detection of IgM phase II antibodies to Coxiella burnetii in the diagnosis of acute Q fever. Ann N Y Acad Sci 1078:561-562
40. Frankel D, Richet H, Renvoise A, Raoult D (2011) Q fever in France, 1985-2009. Emerg Infect Dis 17:350-356
41. Fries LF, Waag DM, Williams JC (1993) Safety and immunogenicity in human volunteers of a choloform-methanol residue vaccine for Q fever. Infect Immun 61:1251-1258
42. Geddes AM (1983) Q fever. Br Med J 287:927-928
43. Genig VA (1968) A live vaccine1/M-44 against Q-fever for oral use. J Hyg Epidemiol Microbiol Immunol 12:265-273
44. Glazunova O, Roux V, Freylikman O, Sekeyova Z, Fournous G, Tyczka J, Tokarevich N, Kovacova E, marrie TJ, Raoult D (2005) Coxiella burnetii genotyping. Emerg Infect Dis 11:1211-1217
45. Guatteo R, Beaudeau F, Joly A, Seegers H (2007) Performances of an ELISA applied to serum and milk for the detection of antibodies to Coxiella burnetii in dairy cattle. Revue Med Vet 158:250-252
46. Hackstadt T (1986) Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun 52:337-340
47. Hellenbrand W, Breuer T, Petersen L (2001) Changing epidemiology of Q fever in Germany, 1947-1999. Emerg Infect Dis 7:789-796
48. Hendrix LR, Samuel JE, mallavia LP (1991) Differentiation of Coxiella burnetii isolates by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE. J Gen Microbiol 137:269-276
49. Hendrix LR, mallavia LP, Samuel JE (1993) Cloning and sequencing of Coxiella burnetii outer membrane protein gene com1 . Infect Immun 61:470-477
50. Hernychova L, Toman R, Ciampor F, Hubalek M, Vackova J, macela A, Skultety L (2008) Detection and identi fication of Coxiella burnetii based on the mass spectrometric analyses of the extracted proteins. Anal Chem 80:7097-7104
51. Hoover TA, Culp DW, Vodkin MH, Williams JC, Thompson HA (2002) Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (Crazy), of the Coxiella burnetii Nine Mile strain. Infect Immun 70:6726-6733
52. Hoover TA, Vodkin MH, Williams JC (1992) A Coxiella burnetii repeated DNA element resembling a bacterial insertion sequence. J Bacteriol 174:5540-5548
53. Howe D, Barrows LF, Lindstrom NM, Heinzen RA (2002) Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect Immun 70:5140-5147
54. Izzo AA, marmion BP, Hackstadt T (1991) Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin Exp Immunol 85:98-108
55. Jager C, Willems H, Thiele D, Baljer G (1998) Molecular characterization of Coxiella burnetii isolates. Epidemiol Infect 120:157-164
56. Jensen TK, Montgomery DL, Jaeger PT, Lindhardt T, Agerholm JS, Bille-Hansen V, Boye M (2007) Application of fluorescent in situ hybridization for demonstration of Coxiella burnetii in placentas from ruminant abortions. APMIS 115:347-353
57. Johnson JW, Eddy GA, Pederson CE Jr (1976) Biologic properties of the M-44 strain of Coxiella burnetii . J Infect Dis 133:334-338
58. Johnson JW, McLeod CG, Stookey JL, Higbee GA, Pedersen CE Jr (1977) Lesions in guinea pigs infected with Coxiella burnetii strain M-44. J Infect Dis 135:995-998
59. Kazar J, El-Najdawi E, Brezina R, Schramek S (1977) Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii . Acta Virol 21:422-430
60. Kazar J, Brezina R, Palanova A, Turda B, Schramek S (1982) Immunogenicity and reactogenicity of Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull World Health Organ 60:389-394
61. Kazar J, Votruba D, Propper P, Schramek S (1986) Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines. Acta Virol 30:499-506
62. Klaassen CHW, Nabuurs-Franssen MH, Tilburg JJHC, Hamans maWM, Horrevorts AM (2009) Multigenotype Q fever outbreak, the Netherlands. Emerg Infect Dis 15:613-614
63. La Scola B (2002) Current laboratory diagnosis of Q fever. Semin Pediatr Infect Dis 13:257-262
64. Li Q, Niu D, Wen B, Chen M, Qiu L, Zhang J (2005) Protective immunity against Q fever induced with a recombinant PI antigen fused with HspB of Coxiella burnetii . Ann N Y Acad Sci 1063:130-142
65. Lukacova M, Gajdosova E, Skultety L, Kovacova E, Kazar J (1994) Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB. Eur J Epidemiol 10:227-230
66. Lukacova M, Barak I, Kazar J (2008) Role of structural variations of polysaccharide antigens in the pathogenicity of Gram-negative bacteria. Clin Microbiol Infect 14:200-206
67. Luoto L, Casey ML, Pickens EG (1965) Q fever studies in Montana: detection of asymptomatic infection among residents of infected dairy premises. Am J Epidemiol 81:356-369
68. marmion B (2007) Q fever: the long journey to control by vaccination. Med J Aust 186:164-166
69. marmion BP, Storm PA, Ayres JG, Semendric L, mathews L, Winslow W, Turra M, Harris RJ (2005) Long-term persistence of Coxiella burnetii after acute primary Q fever. Q J Med 98:7-20
70. Meiklejohn G, Reimer LG, Graves PS, Helmick C (1981) Cryptic epidemic of Q fever in a medical school. J Infect Dis 144:107-113
71. Million M, Thuny F, Richet H, Raoult D (2010) Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 10:527-535
72. Moos A, Hackstadt T (1987) Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun 55:1144-1150
73. Morisawa Y, Wakiguchi H, Takechi T, Kurashige T, Nagaoka H (2001) Intractable Q fever treated with recombinant gamma interferon. Pediatr Infect Dis J 20:546-547
74. Muller HP, Schmeer N, Rantamaki L, Semler B, Krauss H (1987) Isolation of a protein antigen from Coxiella burnetii . Zentralbl Bakteriol Mikrobiol Hyg A 265:277-289
75. Narasaki CT, Mertens K, Samuel JE (2011) Characterization of the GDP-D-mannose biosynthesis pathway in Coxiella burnetii: the initial steps for GDP- b -D-virenose biosynthesis. PLoS One 6(10):e25514
76. Neth OW, Falcon D, Peromingo E, Soledad Camacho M, Rodriguez-Gallego C, Obando I (2011) Successful management of chronic multifocal Q fever osteomyelitis with adjuvant interferongamma therapy. Pediatr Infect Dis J 30(9):810-812
77. Omsland A, Cockrell DC, Fischer ER, Heinzen RA (2008) Sustained axenic metabolic activity by the obligate intracellular bacterium Coxiella burnetii . J Bacteriol 190:3203-3212
78. Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, Sturdevant DE, Porcella SF, Heinzen RA (2009) Host cell-free growth of the Q fever bacterium Coxiella burnetii . Proc Natl Acad Sci U S A 106:4430-4434
79. Ormsbee RA, marmion BP (1990) The disease. In: marrie TJ (ed) Q fever, vol 1. CRC Press, Boca Raton, p 226
80. Ormsbee RA, Bell EJ, Lackman DB, Tallent G (1964) The in fluence of phase on the protective potency of Q fever vaccine. J Immunol 92:404-412
81. Palkovicova K, Ihnatko R, Vadovic P, Betinova E, Skultety L, Frangoulidis D, Toman R (2009) A monoclonal antibody speci fic for a unique biomarker, virenose, in a lipopolysaccharide of Coxiella burnetii. Clin Microbiol Infect 15:183-184
82. Panning M, Kilwinski J, Greiner-Fischer S, Peters M, Kramme S, Frangoulidis D, Meyer H, Henning K, Drosten C (2008) High throughput detection of Coxiella burnetii by real-time PCR with internal control system and automated DNA preparation. BMC Microbiol 8:77-84
83. Peter O, Dupuis G, Peacock MG, Burgdorfer W (1987) Comparison of enzyme-linked immunosorbent assay and complement fixation and indirect fluorescent-antibody tests for detection of Coxiella burnetii antibody. J Clin Microbiol 25:1063-1067
84. Pierce CY, Barr JR, Wool fitt AR, Moura H, Shaw EI, Thompson HA, massung RF, Fernandez FM (2007) Strain and phase identi fication of the U.S. category B agent Coxiella burnetii by matrix assisted laser desorption/ionization time-of- flight mass spectrometry and multivariate pattern recognition. Anal Chem Acta 583:23-31
85. Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P (1999) Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and o floxacin or hydroxychloroquine. Arch Intern Med 159:167-173
86. Redd T, Thompson HA (1995) Secretion of proteins by Coxiella burnetii . Microbiology 141:363-369
87. Richardus JH, Donkers A, Dumas AM, Schaap GJP, Akkermans JPWM, Huisman J, Valkenburg HA (1987) Q fever in the Netherlands: a sero-epidemiological survey among human population groups from 1968-1983. Epidemiol Infect 98:211-219
88. Russel-Lodrigue KE, Andoh M, Poels MW, Shive HR, Weeks BR, Zhang GQ, Tersteeg T, masegi T, Hotta A, Yamaguchi T, Fukushi H, Hirai K, McMurray DN, Samuel JE (2009) Coxiella burnetii isolates cause genogroup speci fic virulence in mouse and guinea pig models of acute Q fever. Infect Immun 77:5640-5650
89. Samoilis G, Aivaliotis M, Vranakis I, Papadioti A, Tselentis Y, Tsiotis G, Psaroulaki A (2010) Proteomic screening for possible effector molecules secreted by the obligate intracellular pathogen Coxiella burnetii . J Proteome Res 9:1619-1626
90. Sawyer LA, Fishbein DB, McDade JE (1987) Q fever: current concepts. Rev Infect Dis 9:935-946
91. Schmeer N, Muller P, Langel J, Krauss H, Frost JW, Wieda J (1987) Q fever vaccines for animals. Zentralbl Bakteriol Microbiol Hyg A 267:79-88
92. Schmeer N, Muller H-P, Baumgartner W, Wieda J, Krauss H (1988) Enzyme-linked immunosorbent fluorescence assay and high-pressure liquid chromatography for analysis of humoral immune responses to Coxiella burnetii proteins. J Clin Microbiol 26:2520-2525
93. Schneeberger PM, Hermans MHA, van Hannen EJ, Schellekens JJA, Leenders ACAP, Wever PC (2010) Real-time PCR with serum samples is indispensible for early diagnosis of acute Q fever. Clin Vaccine Immunol 17:286-290
94. Schramek S, mayer H (1982) Different sugar compositions of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii. Infect Immun 38:53-57
95. Sekeyova Z, Kowalczewska M, Decloquement P, Pelletier N, Spitalska E, Raoult D (2009) Identi fication of protein candidates for the serodiagnosis of Q fever endocarditis by an immunoproteomic approach. Eur J Clin Microbiol Infect Dis 28:287-295
96. Sekeyova Z, Kowalczewska M, Vincentelli R, Decloquement P, Flores-Ramirez G, Skultety L, Raoult D (2010) Characterization of antigens for Q fever serodiagnostics. Acta Virol 54:173-180
97. Shaw EI, Moura H, Wool fitt AR, Ospina M, Thompson HA, Barr JR (2004) Identi fication of biomarkers of whole Coxiella burnetii phase I by maLDI-TOF mass spectrometry. Anal Chem 76:4017-4022
98. Smadel JE, Snyder MJ, Robbins FC (1948) Vaccination against Q fever. Am J Hyg 47:71
99. Stein A, Kruszewska D, Gouvernet J, Raoult D (1997) Study of the 16S-23S ribosomal DNA internal spacer of Coxiella burnetii . Eur J Epidemiol 13:471-475
100. Stoker MG, Fiset P (1956) Phase variation of the Nine Mile and other strains of Rickettsia burnetii . Can J Microbiol 2:310-321
101. Svraka S, Toman R, Skultety L, Slaba K, Homan WL (2006) Establishment of a genotyping scheme for Coxiella burnetii . FEMS Microbiol Lett 254:268-274
102. Thiele D, Willems H, Krauss H (1994) The 16S/23S ribosomal spacer region of Coxiella burnetii . Eur J Epidemiol 10:421-426
103. Tilburg JJHC, Melchers WJG, Pettersson AM, Rossen JWA, Hermans MHA, van Hannen EJ, Nabuurs-Franssen MH, de Vries MC, Horrevorts AM, Klaassen CHW (2010) Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum. J Clin Microbiol 48:3923-3927
104. Tissot-Dupont H, Vaillant V, Rey S, Raoult D (2007) Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 44:232-237
105. To H, Hotta A, Zhang GQ, Nguyen SV, Ogawa M, Yamaguchi T, Fukushi H, Amano K, Hirai K (1998) Antigenic characteristics of polypeptides of Coxiella burnetii isolates. Microbiol Immunol 42:81-85
106. Varghees S, Kiss K, Frans G, Braha O, Samuel J (2002) Cloning and porin activity of the outer membrane protein P1 from Coxiella burnetii . Infect Immun 70:6741-6750
107. Vigil A, Ortega R, Nakajima-Sasaki R, Pablo J, Molina DM, Chao C-C, Chen H-W, Ching W-M, Felgner PL (2010) Genome-wide pro filing of humoral immune response to Coxiella burnetii infection by protein microarray. Proteomics 10:2259-2269
108. Vigil A, Chen C, Jain A, Nakajima-Sasaki R, Jasinskas A, Pablo J, Hendrix LR, Samuel JE, Felgner PL (2011) Pro filing the humoral immune response of acute and chronic Q fever by protein microarray. Mol Cell Proteomics 10(10):M110.006304
109. Vodkin MH, Williams JC (1986) Overlapping deletion in two spontaneous phase variants of Coxiella burnetii. J Gen Microbiol 132:2587-2594
110. Vodkin MH, Williams JC, Stephenson EH (1986) Genetic heterogeneity among isolates of Coxiella burnetii . J Gen Microbiol 132:455-463
111. Waag DM, Bolt CR, marrie TJ, Williams JC (1991) The biology of Coxiella burnetii . In: Williams JC, Thompson HA (eds) Q fever. CRC Press, Boca Raton, pp 164-167
112. Waag DM, England MJ, Pitt ML (1997) Comparative ef ficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15:1779-1783
113. Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Ban field CM (2002) Comparative ef ficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccine in cynomolgus monkeys challenged by aerosol. Vaccine 20:2623-2634
114. Waag DM, England MJ, Bolt CR, Williams JC (2008) Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii . Clin Vaccine Immunol 15:1505-1512
115. Williams JC, Cantrell JL (1982) Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infect Immun 35:1091-1102
116. Williams JC, Damrow TA, Waag DM, Amano K (1986) Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10ScN mice. Infect Immun 51:851-858
117. Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH (1990) Vaccines against coxiellosis and Q fever. Ann N Y Acad Sci 590:88-111
118. Wisniewski HJ, Kleiman MW, Lackman DB, Krumbiegel ER (1969) Demonstration of inapparent infection with disease agents common to animals and man. Health Lab Sci 6:173-177
119. Zhang GQ, Samuel JE (2003) Identi fication and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci 990:510-520
120. Zhang YX, Zhi N, Yu SR, Li QR, Yu GC, Zhang X (1994) Protective immunity induced by 67K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs. Acta Virol 38:327-332
121. Zhang GQ, Kiss K, Seshadri R, Hendrix LR, Samuel J (2004) Identi fication and cloning of immunodominant antigens of Coxiella burnetii . Infect Immun 72:844-852
122. Zhang G, To H, Russell KE, Hendrix LR, Yamaguchi T, Fukushi H, Hirai K, Samuel JE (2005) Identi fication and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein speci fic to isolates associated with acute disease. Infect Immun 73:1561-1567
123. Zhang G, Russell-Lodrigue KE, Andoh M, Zhang Y, Hendrix LR, Samuel JE (2007) Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J Immunol 179:8372-8380